Sunnyvale, CA (PRWEB) August 09, 2012
American Peptide Company (APC) announces the release of the 25th Anniversary Edition of their peptide catalog. American Peptide Company is dedicated to serving the life science community by providing tools for peptide research.
A whole array of Phalloidin peptides, Phalloidin derivatives and their fluorescent conjugates has been added to the catalog. The Phalloidins are complemented with a new technical notes section. In addition to the Phalloidins, sixteen new peptides spanning a variety of functional areas have been added to the catalog.
The 25th Anniversary Peptide Catalog contains over 1,900 diverse products, including beta-amyloid, antimicrobial, endothelin, neuropeptide, LHRH, ACTH, angiotensin, exendin, glucagon, ghrelin and diabetes related peptides.
The new catalog features updated product references, enhanced technical details and improved indexes.
“We have been focused on making peptides for 25 years and have much experience synthesizing complex sequences and purifying difficult and hydrophobic peptides,” says John McKinley, Sr. Marketing Manager.
To request a complimentary copy of the new APC print catalog visit http://www.americanpeptide.com or send an email to marketing(at)americanpeptide(dot)com.
About American Peptide Company, Inc.
American Peptide Company (APC) is a leading manufacturer of peptides and peptide conjugates. The company offers comprehensive selections of pre-manufactured catalog peptides, custom synthesis, and GMP peptide active pharmaceutical ingredients (APIs). Our California based manufacturing facilities offer synthesis services under Non GMP (Sunnyvale, California) and cGMP (Vista, California) conditions. Our cGMP manufacturing is performed under strict adherence to FDA Regulations 21 CFR parts 210, 211 and ICH Guidance Q7A. Our Total Peptide Management services support clients in the drug development process from pre-clinical thru commercial stage. Our value added services include process development, scale up production, analytical/process validation, stability studies, CMC, DMF, and regulatory support.
APC is proficient in solid-phase and solution-phase peptide synthesis, as well as organic conjugations, proteins and PEGylation. APC is a wholly-owned subsidiary of ILS Inc., a member of the Otsuka Chemical Company of Japan. APC has offices in the U.S. and representatives in Japan, South Korea, the UK, and China. APC has recently increased their large scale cGMP manufacturing capabilities with additional synthesis and purification suites, a 160 liter solid phase synthesis reactor, a 12” RP-HPLC column and a 294 liter tray lyophilizer.
For more information, please visit http://www.americanpeptide.com.